The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

The impact be especially strong on users of some formulations of testosterone, an antidepressant and an anti-brain-bleed drug ...

Net prices that health plans paid for medicines rose a modest 0.4% in the fourth quarter, but that compared unfavorably with ...

TORONTO—Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to new research ...

As managed care pharmacy navigates rapid transformations in policies, high-cost drug strategies, and innovative therapies, ...

A group of former Wells Fargo employees failed to prove the bank neglected its fiduciary duties over its health plan’s ...

During last year’s enrollment period, millions of Medicare beneficiaries reviewed their coverage options and selected new ...

Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.